Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q90783050
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241221010744.0 |
008
|
|
|
241221nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q90783050
|
024
|
|
|
‡a
0000-0001-8451-7389
‡2
orcid
|
035
|
|
|
‡a
(OCoLC)Q90783050
|
100
|
0 |
|
‡a
Nils Peters
‡c
researcher (ORCID 0000-0001-8451-7389)
‡9
en
|
400
|
0 |
|
‡a
Nils Peters
‡c
onderzoeker
‡9
nl
|
670
|
|
|
‡a
Author's Brain atrophy is related to lacunar lesions and tissue microstructural changes in CADASIL.
|
670
|
|
|
‡a
Author's Feasibility of rapid measurement of Rivaroxaban plasma levels in patients with acute stroke
|
670
|
|
|
‡a
Author's Frequency and Determinants of Adherence to Oral Anticoagulants in Stroke Patients with Atrial Fibrillation in Clinical Practice.
|
670
|
|
|
‡a
Author's Impact of MRI markers in subcortical vascular dementia: a multi-modal analysis in CADASIL.
|
670
|
|
|
‡a
Author's Intravenous Thrombolysis in Patients Dependent on the Daily Help of Others Before Stroke.
|
670
|
|
|
‡a
Author's Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice.
|
670
|
|
|
‡a
Author's Ischemic brain lesions after carotid artery stenting increase future cerebrovascular risk
|
670
|
|
|
‡a
Author's IV thrombolysis and renal function.
|
670
|
|
|
‡a
Author's Long-term outcome in stroke patients treated with IV thrombolysis.
|
670
|
|
|
‡a
Author's Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome
|
670
|
|
|
‡a
Author's Serum Neurofilament Light Chain Levels Are Associated with Clinical Characteristics and Outcome in Patients with Cervical Artery Dissection.
|
670
|
|
|
‡a
Author's Small vessel disease is associated with an unfavourable outcome in stroke patients on oral anticoagulation
|
670
|
|
|
‡a
Author's Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT
|
909
|
|
|
‡a
(orcid) 0000000184517389
‡9
1
|
919
|
|
|
‡a
brainatrophyisrelatedtolacunarlesionsandtissuemicrostructuralchangesincadasil
‡A
Brain atrophy is related to lacunar lesions and tissue microstructural changes in CADASIL.
‡9
1
|
919
|
|
|
‡a
feasibilityofrapidmeasurementofrivaroxabanplasmalevelsinpatientswithacutestroke
‡A
Feasibility of rapid measurement of Rivaroxaban plasma levels in patients with acute stroke
‡9
1
|
919
|
|
|
‡a
frequencyanddeterminantsofadherencetooralanticoagulantsinstrokepatientswithatrialfibrillationinclinicalpractice
‡A
Frequency and Determinants of Adherence to Oral Anticoagulants in Stroke Patients with Atrial Fibrillation in Clinical Practice.
‡9
1
|
919
|
|
|
‡a
impactofmrimarkersinsubcorticalvasculardementiaamultimodalanalysisincadasil
‡A
Impact of MRI markers in subcortical vascular dementia: a multi-modal analysis in CADASIL.
‡9
1
|
919
|
|
|
‡a
intravenousthrombolysisinpatientsdependentonthedailyhelpofothersbeforestroke
‡A
Intravenous Thrombolysis in Patients Dependent on the Daily Help of Others Before Stroke.
‡9
1
|
919
|
|
|
‡a
intravenousthrombolysisinpatientswithstroketakingrivaroxabanusingdrugspecificplasmalevelsexperiencewithastandardoperationprocedureinclinicalpractice
‡A
Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice.
‡9
1
|
919
|
|
|
‡a
ischemicbrainlesionsaftercarotidarterystentingincreasefuturecerebrovascularrisk
‡A
Ischemic brain lesions after carotid artery stenting increase future cerebrovascular risk
‡9
1
|
919
|
|
|
‡a
4thrombolysisandrenalfunction
‡A
IV thrombolysis and renal function.
‡9
1
|
919
|
|
|
‡a
longtermoutcomeinstrokepatientstreatedwith4thrombolysis
‡A
Long-term outcome in stroke patients treated with IV thrombolysis.
‡9
1
|
919
|
|
|
‡a
recanalizationtherapiesinacuteischemicstrokepatientsimpactofpriortreatmentwithnoveloralanticoagulantsonbleedingcomplicationsandoutcome
‡A
Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome
‡9
1
|
919
|
|
|
‡a
serumneurofilamentlightchainlevelsareassociatedwithclinicalcharacteristicsandoutcomeinpatientswithcervicalarterydissection
‡A
Serum Neurofilament Light Chain Levels Are Associated with Clinical Characteristics and Outcome in Patients with Cervical Artery Dissection.
‡9
1
|
919
|
|
|
‡a
smallvesseldiseaseisassociatedwithanunfavourableoutcomeinstrokepatientsonoralanticoagulation
‡A
Small vessel disease is associated with an unfavourable outcome in stroke patients on oral anticoagulation
‡9
1
|
919
|
|
|
‡a
tranexamicacidtoimprovefunctionalstatusinadultswithspontaneousintracerebralhaemorrhagethetich2rct
‡A
Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT
‡9
1
|
996
|
|
|
‡2
ISNI|0000000116482348
|
996
|
|
|
‡2
SIMACOB|238646627
|
996
|
|
|
‡2
DNB|1036930033
|
996
|
|
|
‡2
NUKAT|n 2010140384
|
996
|
|
|
‡2
NSK|000465120
|
996
|
|
|
‡2
CAOONL|ncf11440803
|
996
|
|
|
‡2
CAOONL|ncf11688349
|
996
|
|
|
‡2
DNB|12309948X
|
996
|
|
|
‡2
NTA|229496539
|
996
|
|
|
‡2
DNB|1238831567
|
996
|
|
|
‡2
W2Z|1523345892602
|
996
|
|
|
‡2
BNF|14428887
|
996
|
|
|
‡2
J9U|987007334931805171
|
996
|
|
|
‡2
DNB|1055105387
|
996
|
|
|
‡2
ISNI|0000000102824597
|
996
|
|
|
‡2
NTA|306095114
|
996
|
|
|
‡2
SUDOC|112864961
|
996
|
|
|
‡2
ISNI|0000000055449770
|
996
|
|
|
‡2
LIH|LNB:CO_c__k_;=B_w_
|
996
|
|
|
‡2
ISNI|0000000140155937
|
996
|
|
|
‡2
NKC|xx0217592
|
996
|
|
|
‡2
DNB|13176277X
|
996
|
|
|
‡2
LC|n 2007165375
|
996
|
|
|
‡2
BIBSYS|1523345892602
|
996
|
|
|
‡2
NTA|298679477
|
996
|
|
|
‡2
LC|nr2007008768
|
996
|
|
|
‡2
SUDOC|077390288
|
996
|
|
|
‡2
DNB|128717890
|
996
|
|
|
‡2
DNB|1045620157
|
996
|
|
|
‡2
DBC|87097991834081
|
996
|
|
|
‡2
ISNI|0000000117782676
|
996
|
|
|
‡2
DNB|139828478
|
996
|
|
|
‡2
DNB|1095775553
|
996
|
|
|
‡2
NTA|130481734
|
996
|
|
|
‡2
RERO|A011359447
|
996
|
|
|
‡2
BIBSYS|5068385
|
996
|
|
|
‡2
LC|no2014012603
|
996
|
|
|
‡2
SUDOC|279202504
|
996
|
|
|
‡2
LC|no2008061567
|
996
|
|
|
‡2
ISNI|0000000047911056
|
996
|
|
|
‡2
DNB|1350474703
|
996
|
|
|
‡2
DNB|1308374313
|
996
|
|
|
‡2
DNB|1251244718
|
996
|
|
|
‡2
DNB|141942436
|
996
|
|
|
‡2
BIBSYS|6012444
|
996
|
|
|
‡2
BIBSYS|4019161
|
996
|
|
|
‡2
RERO|A024315752
|
996
|
|
|
‡2
DNB|1246551500
|
996
|
|
|
‡2
NII|DA18379842
|
996
|
|
|
‡2
ISNI|0000000434863074
|
996
|
|
|
‡2
NUKAT|n 2007111348
|
996
|
|
|
‡2
ISNI|0000000391351094
|
996
|
|
|
‡2
DNB|1055362916
|
996
|
|
|
‡2
DNB|140753907
|
996
|
|
|
‡2
LC|no2011135196
|
996
|
|
|
‡2
DNB|138212791
|
996
|
|
|
‡2
LC|n 98095743
|
996
|
|
|
‡2
LC|nb2008007924
|
996
|
|
|
‡2
NTA|413969851
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|